Clinical Trials Browser

Terminated × INDUSTRY × troxacitabine × Clear all

NCT00104468 2008-01-17

Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML)

Phase 1/2 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00104286 2006-11-03

Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Solid Tumors

Phase 1/2 Terminated

Neoplasms

NCT00129948 2006-11-03

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 2 Terminated

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute